(1)
Kemanetzi, C.; Lallas, K.; Lazaridou, E.; Papageorgiou, C.; Lallas, A.; Stratigos, A.; Timotheadou, E.; Lazaridis, G.; Dionysopoulos, D.; Kalaitzi, K.; Tsimpidakis, A.; Trakatelli, M.; Patsatsi, A.; Nikolaou, V.; Apalla, Z. The Impact of Immune Checkpoint Inhibitors-Induced Skin Toxicity on Patients’ Quality of Life and the Role of Dermatologic Intervention. Dermatol Pract Concept 2024, 14 (3), e2024118. https://doi.org/10.5826/dpc.1403a118.